Asempa, T. E., Kuti, J. L., Nascimento, J. C., Pope, S. J., Salerno, E. L., Troy, P. J., & Nicolau, D. P. (2023). Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects. Journal of antimicrobial chemotherapy, 78(3), 703-709. https://doi.org/10.1093/jac/dkac447
Chicago-Zitierstil (17. Ausg.)Asempa, Tomefa E., Joseph L. Kuti, Jeffrey C. Nascimento, Samuel J. Pope, Edward L. Salerno, Patrick J. Troy, und David P. Nicolau. "Bronchopulmonary Disposition of IV Cefepime/taniborbactam (2–0.5 G) Administered over 2 H in Healthy Adult Subjects." Journal of Antimicrobial Chemotherapy 78, no. 3 (2023): 703-709. https://doi.org/10.1093/jac/dkac447.
MLA-Zitierstil (9. Ausg.)Asempa, Tomefa E., et al. "Bronchopulmonary Disposition of IV Cefepime/taniborbactam (2–0.5 G) Administered over 2 H in Healthy Adult Subjects." Journal of Antimicrobial Chemotherapy, vol. 78, no. 3, 2023, pp. 703-709, https://doi.org/10.1093/jac/dkac447.